Ryerson director receives 389-share equity grant

CALHOUN KIRK K reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

CALHOUN KIRK K reported acquisition or exercise transactions in this Form 4 filing.

Ryerson Holding Corp director Kirk K. Calhoun received a grant of 389 shares of common stock as equity compensation under Ryerson's Director Compensation Program. The award vested in full on the grant date. Following this grant, Calhoun directly holds 4,576 shares of Ryerson common stock.

Insider Trade Summary

Grant/Award: 389 shares

Grant/Award 1 txn

Insider CALHOUN KIRK K

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock (par value $0.01 per share)	389	$0.00	$0.00

Holdings After Transaction: Common Stock (par value $0.01 per share) — 4,576 shares (Direct)

Footnotes (1)

1. F1. Reflects compensation in the form of equity received pursuant to Ryerson's Director Compensation Program. The award vested in full on the grant date.

Key Figures

Equity award shares: 389 shares Award price per share: $0.00 per share Shares held after grant: 4,576 shares

3 metrics

Equity award shares 389 shares Common Stock grant under Director Compensation Program

Award price per share $0.00 per share Stated transaction price for equity grant

Shares held after grant 4,576 shares Total direct holdings following transaction

Key Terms

Director Compensation Program, grant/award acquisition, Common Stock (par value $0.01 per share)

3 terms

Director Compensation Program financial

"Reflects compensation in the form of equity received pursuant to Ryerson's Director Compensation Program."

grant/award acquisition financial

"transaction_action": "grant/award acquisition""

Common Stock (par value $0.01 per share) financial

"security_title": "Common Stock (par value $0.01 per share)""

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Ryerson (RYI) director Kirk K. Calhoun report in this Form 4?

Kirk K. Calhoun reported receiving a grant of 389 shares of Ryerson common stock. This was equity compensation under the Director Compensation Program and vested immediately on the grant date, increasing his direct holdings to 4,576 shares.

Was the Ryerson (RYI) Form 4 transaction a market purchase or sale?

The Form 4 shows an equity award, not a market trade. Calhoun received 389 shares at a stated price of $0.00 per share as compensation, classified as a grant or award acquisition rather than an open-market purchase or sale.

How many Ryerson (RYI) shares does Kirk K. Calhoun hold after this grant?

After receiving 389 shares in this equity grant, Calhoun directly holds 4,576 shares of Ryerson common stock. This total reflects his position immediately following the reported transaction on the Form 4 filing date.

What is Ryerson’s Director Compensation Program mentioned in the Form 4?

The Form 4 notes that the 389-share grant reflects equity compensation under Ryerson's Director Compensation Program. While detailed terms are not provided here, the filing specifies that this particular award vested in full on the grant date.

Did the Ryerson (RYI) director equity award vest immediately?

Yes. The footnote explains that the 389-share equity award to director Kirk K. Calhoun vested in full on the grant date. This means all granted shares became fully owned and no vesting schedule remains attached to this specific award.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/13/2026 - 08:44 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

CALHOUN KIRK K

(Last) (First) (Middle)

C/O RYERSON HOLDING CORPORATION

227 W. MONROE ST., 27TH FLOOR

(Street)

CHICAGO ILLINOIS 60606

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Ryerson Holding Corp [ RYZ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock (par value $0.01 per share)	04/10/2026		A		389(1)	A	$0	4,576	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects compensation in the form of equity received pursuant to Ryerson's Director Compensation Program. The award vested in full on the grant date.

	/s/ Camilla Rykke Merrick, attorney-in-fact	04/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)